Author: Pinna, Pranusha; Grewal, Parneet; Hall, Julianne P.; Tavarez, Tachira; Dafer, Rima M.; Garg, Rajeev; Osteraas, Nicholas D.; Pellack, Danielle R.; Asthana, Anjali; Fegan, Kelsey; Patel, Vikram; Conners, James J.; John, Sayona; Silva, Ivan Da
Title: Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline Cord-id: e15xwcyc Document date: 2020_8_15
ID: e15xwcyc
Snippet: OBJECTIVE: To report neurological manifestations seen in patients hospitalized with Coronavirus disease 2019 (COVID-19) from a large academic medical center in Chicago, Illinois. METHODS: We retrospectively reviewed data records of 50 patients with COVID-19 who were evaluated by the neurology services from March 1, 2020 - April 30, 2020. Patients were categorized into 2 groups based on timing of developing neurological manifestations: the “Neuro first†group had neurological manifestations u
Document: OBJECTIVE: To report neurological manifestations seen in patients hospitalized with Coronavirus disease 2019 (COVID-19) from a large academic medical center in Chicago, Illinois. METHODS: We retrospectively reviewed data records of 50 patients with COVID-19 who were evaluated by the neurology services from March 1, 2020 - April 30, 2020. Patients were categorized into 2 groups based on timing of developing neurological manifestations: the “Neuro first†group had neurological manifestations upon initial assessment, and the “COVID first†group developed neurological symptoms greater than 24 h after hospitalization. The demographics, comorbidities, disease severity and neurological symptoms and diagnoses of both groups were analyzed. Statistical analysis was performed to compare the two groups. RESULTS: A total of 50 patients (48% African American and 24% Latino) were included in the analysis. Most common neurological manifestations observed were encephalopathy (n = 30), cerebrovascular disease (n = 20), cognitive impairment (n = 13), seizures (n = 13), hypoxic brain injury (n = 7), dysgeusia (n = 5), and extraocular movement abnormalities (n = 5). The “COVID-19 first†group had more evidence of physiologic disturbances on arrival with a more severe/critical disease course (83.3% vs 53.8%, p 0.025). CONCLUSION: Neurologic manifestations of COVID-19 are highly variable and can occur prior to the diagnosis of or as a complication of the viral infection. Despite similar baseline comorbidities and demographics, the COVID-19 patients who developed neurologic symptoms later in hospitalization had more severe disease courses. Differently from previous studies, we noted a high percentage of African American and Latino individuals in both groups.
Search related documents:
Co phrase search for related documents- academic center and lung inflammation: 1
- long term outcome and lung inflammation: 1
Co phrase search for related documents, hyperlinks ordered by date